retatrutide clinical trial dose Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Retatrutide Dosing Guide for Researchers

The use of weight-loss medications like semaglutide is becoming more and more popular

Additionally, several agents currently being investigated for obesity management will be highlighted

Both forms contain the same active ingredient (semaglutide)

Early GLP-1 manufacturers, including Novo Nordisk and Eli Lilly, originally developed the drug to help with blood sugar control in adults with type 2 diabetes, but weight loss has since become the primary driver of adoption, he says

Its not just about following instructions

Pregnancy and breastfeeding status must be clarified with your healthcare team, since data in those populations is limited